Moreover, this population was stabilized by epigenetic modifications driven by MAFG and MAT2α signaling, further supporting the notion that epigenetic changes to the CNS contribute to MS pathogenesis (Huynh et al., 2014). The gene discussed is MAFG; the disease is myeloid sarcoma.